Landmark Ideas Series: Karen Copenhaver

Speaker: Karen Copenhaver, at Non-profits

Date: November 3, 2022 at 4:00PM - 5:30PM

Talk Topic: Using Licensing to Maximize Innovation in The Open Source Software Ecosystem.

Karen Copenhaver is listed in The International Who's Who of Internet & e-Commerce Lawyers, Chambers USA, Who’s Who Legal, Best Lawyers in America and among the top 50 women Massachusetts Super Lawyers. Ms. Copenhaver was named "Lawyer of the Year" in Boston for information technology law by Best Lawyers 2018. She was named a 2013 “Top Woman of Law” by Massachusetts Lawyers Weekly. She was also named the 2016 Boston “Lawyer of the Year” for Information Technology Law by Best Lawyers, a designation she also received in 2013 for Copyright Law and in 2014 and 2012 for Information Technology Law, and has been named in The Legal 500 for technology transactions. Ms. Copenhaver is only the 5th lawyer ever to receive Mass High Tech'sprestigious “Mass High Tech All-Stars Award,” which honors the thought leaders and innovators throughout the New England technology sector. She has been chosen by Intellectual Asset Management magazine as one of the world’s top IP strategists in their feature “IAM 250 — A Guide to the World’s Leading IP Strategists.” She has also been named a top patent and technology licensing practitioner in IAM Licensing 250 and a world’s leading patent practitioner in IAM Patent 1000. She has been recognized by Managing Intellectual Property as an “IP Star” and among the “Top 250 Women in IP” nationwide.


Publications

Chen KY, Borglund EM, Postema EC, Dunn AG, Bourgeois FT. Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis. Clinical trials (London, England) 2022.

Le Naour J, Sztupinszki Z, Carbonnier V, Casiraghi O, Marty V, Galluzzi L, Szallasi Z, Kroemer G, Vacchelli E. A loss-of-function polymorphism in compromises therapeutic outcome in head and neck carcinoma patients. Oncoimmunology 2022.

Klann JG, Strasser ZH, Hutch MR, Kennedy CJ, Marwaha JS, Morris M, Samayamuthu MJ, Pfaff AC, Estiri H, South AM, Weber GM, Yuan W, Avillach P, Wagholikar KB, Luo Y, Omenn GS, Visweswaran S, Holmes JH, Xia Z, Brat GA, Murphy SN. Distinguishing Admissions Specifically for COVID-19 from Incidental SARS-CoV-2 Admissions: A National Retrospective EHR Study. Journal of medical Internet research 2022.